Airius PureAir Coronavirus Testing – Impact On Novel COVID19


At Airius we are constantly testing, developing and improving our products and the PureAir Coronavirus testing is something high on our agenda. As defined by the World Health Organization, Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).

The recent COVID-19 illness is an infectious disease caused by the most recently discovered coronavirus. This new virus was unknown before the outbreak began in Wuhan, China, in December 2019.

Is Airius PureAir Technology Effective At Reducing COVID-19?

COVID-19 is a member of the enveloped RNA coronavirus (subgenus sarbecovirus, Orthocoronavirinae) subfamily. While Airius does not have testing specifically on COVID-19, we have validated test results showing 99+% reductions on similar viruses. These viruses, like COVID-19, are also ‘enveloped’ or protein jacketed virus types. If we can reduce these virus types, an assumption could be made that we would also be effective at reducing the current coronavirus at hand. Important to note that we make no medical claims.

Is The Airius PureAir Approved For Use In Hospitals And Healthcare Settings?

Many hospitals have approved and installed the Airius PureAir PHI-Cell technology throughout their facilities.

PureAir Coronavirus Testing On COVID-19

We currently do not have Airius PureAir Coronavirus testing specifically on the Wuhan Coronavirus (COVID-19). We are evaluating testing options with partners in both the U.S. and China. As there are a limited number of facilities capable of testing for this virus, their focus is on prioritising testing as it relates directly to the recent outbreaks.

While reviewing this bulletin Dr. Marsden (KSU) commented, “This virus apparently is similar to other viruses that we previously tested. There is every reason to believe that the Airius PureAir technology would be effective in reduction of COVID-19.” In combination with Airius PureAir technologies it is recommended to always follow antimicrobial protocols and procedures per regulatory guidelines.

Disclaimer: Airius PureAir technology has not been tested on coronavirus (COVID-19) and is not a medical device therefore no medical claims are made. Testing conducted by independent accredited labs and universities.

Airius PureAir Demonstration Video

If you have any questions or queries about the Airius PureAir or PHI Cell, please Contact Us anytime by phone, on +61 (2) 6608 2736 or by email at [email protected].

Stay SAFE!

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Grow with an Industry Leader, Become a Reseller in Australia, S.E. Asia and Beyond - Learn More >>

© 2017 Airius, LLC. All rights reserved.

Call: 1300 985 552